Northwest & Ethical Investments L.P. Adma Biologics, Inc. Transaction History
Northwest & Ethical Investments L.P.
- $4.03 Trillion
- Q2 2025
A detailed history of Northwest & Ethical Investments L.P. transactions in Adma Biologics, Inc. stock. As of the latest transaction made, Northwest & Ethical Investments L.P. holds 23,400 shares of ADMA stock, worth $336,960. This represents 0.01% of its overall portfolio holdings.
Number of Shares
23,400
Previous 9,600
143.75%
Holding current value
$336,960
Previous $190 Million
123.46%
% of portfolio
0.01%
Previous 0.01%
Shares
2 transactions
Others Institutions Holding ADMA
# of Institutions
401Shares Held
191MCall Options Held
2.08MPut Options Held
1.56M-
Vanguard Group Inc Valley Forge, PA21.4MShares$308 Million0.01% of portfolio
-
Black Rock Inc. New York, NY18.6MShares$268 Million0.0% of portfolio
-
Invesco Ltd. Atlanta, GA12.8MShares$185 Million0.04% of portfolio
-
State Street Corp Boston, MA12.1MShares$174 Million0.01% of portfolio
-
Geode Capital Management, LLC Boston, MA5.91MShares$85.1 Million0.01% of portfolio
About ADMA BIOLOGICS, INC.
- Ticker ADMA
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 196,356,992
- Market Cap $2.83B
- Description
- ADMA Biologics, Inc., a biopharmaceutical company, engages in developing, manufacturing, and marketing specialty plasma-derived biologics for the treatment of immune deficiencies and infectious diseases in the United States and internationally. It offers BIVIGAM, an intravenous immune globulin (IVIG) product indicated for the treatment of primar...